Office of Research & Development |
![]() ![]() |
Project Number: | I01BX003168-01A1 |
Title: | Pathogenesis and drug discovery for tauopathy |
Principal Investigator: | Edward A Burton |
Location: | Pittsburgh, PA |
Congressional District Code: | 14 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | October 2016 - September 2021 |
FY 2021 Funding Amount: | $60,000 |
Total Award Amount (all years): |
$703,795 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: DESCRIPTION (provided by applicant): Tauopathies are a group of neurodegenerative diseases that are characterized pathologically by neuronal loss and the accumulation of aggregates of the microtubule-associated protein Tau in surviving CNS neurons. Collectively, these disease, which include progressive supranuclear palsy (PSP), frontotemporal dementia (FTD), chronic traumatic encephalopathy (CTE) and Alzheimer's disease (AD), are a common and important cause of progressive neurologic... |